Company Description
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally.
The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as offers specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members.
It also provides Carepoint devices, which transforms proprietary carts, peripherals, tablets, and TVs into digital access points in clinical settings.
In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services.
Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services.
The company sells its products through field sales professionals, channel partners, and value-added resellers.
It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
| Country | United States |
| Founded | 2006 |
| IPO Date | Sep 17, 2020 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 877 |
| CEO | Ido Schoenberg |
Contact Details
Address: 75 State Street, 26th Floor Boston, Massachusetts 02109 United States | |
| Phone | 617 204 3500 |
| Website | business.amwell.com |
Stock Details
| Ticker Symbol | AMWL |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $18.00 |
| CIK Code | 0001393584 |
| CUSIP Number | 03044L204 |
| ISIN Number | US03044L2043 |
| SIC Code | 7389 |
Key Executives
| Name | Position |
|---|---|
| Dr. Ido Schoenberg M.D. | Chairman and Chief Executive Officer |
| Dr. Roy Schoenberg M.D., M.P.H. | Executive Vice Chairman |
| Mark J. Hirschhorn CPA | Executive Vice President, Chief Operating Officer and Chief Financial Officer |
| Phyllis I. Gotlib | President of Amwell International |
| Paul Francis McNeice | Vice President of Accounting |
| Dan Zamansky | Chief Product and Technology Officer |
| Sue Dooley | Head of Investor Relations |
| Anna Nesterova | Head of Legal |
| Amber Howe | Chief People Officer |
| Dr. Cynthia Horner FAAFP, M.D. | Chief Medical Officer and President of Amwell Medical Group |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 1, 2025 | 144 | Filing |
| Jun 17, 2025 | 8-K | Current Report |
| Jun 2, 2025 | 144 | Filing |
| May 15, 2025 | SCHEDULE 13G/A | Filing |
| May 1, 2025 | 144 | Filing |
| May 1, 2025 | 10-Q | Quarterly Report |
| May 1, 2025 | 8-K | Current Report |
| Apr 23, 2025 | ARS | Filing |
| Apr 23, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 23, 2025 | DEF 14A | Other definitive proxy statements |